Synopsys has seen its share price fall sharply this year, and that slide puts the focus squarely on what investors are really paying for, its future cash flows. With the stock well below recent highs, the key issue is whether the current US$367.70 level lines up with what the underlying business can generate in cash over time.
The issue now is whether the stock's recent pullback leaves Synopsys trading in line with what its projected cash flows imply as a fair price.
If you want to sanity check Synopsys against other opportunities built around cash flow and fundamentals, compare it with companies in the 34 high quality undervalued stocks.
The Discounted Cash Flow (DCF) approach here looks at the cash Synopsys can generate for shareholders over time and then discounts it back to today. On this model, the latest twelve month free cash flow comes in at about $2.7b, already a sizeable base for a software focused business that leans on licensing and recurring contracts.
Analysts feeding into this DCF expect Synopsys to keep growing free cash flow over the next decade, with projections indicating higher levels by 2030 than today. When those future cash flows are discounted and compared with the current share price of $367.70, the DCF projections put Synopsys' estimated intrinsic value meaningfully above the current share price. That gap is what the detailed valuation work is trying to explain, and it is where readers can decide whether the current discount to those cash flows is attractive enough. Find out what Synopsys could be worth using our Discounted Cash Flow (DCF) estimate.
Synopsys' Simply Wall St Narratives pick up where the cash flow puzzle leaves off. They explain which assumptions on growth, profitability and earnings would need to hold for the stock to be worth materially more or materially less than today. Each scenario links a fair value to a specific version of Synopsys' future, connecting potential catalysts and risks so you can track over time which storyline is actually unfolding on the Community page.
One of the top community narratives on Synopsys: 33% undervalued
"The accelerating complexity and proliferation of AI, high-performance computing, and multi-die/chiplet-based architectures are increasing customer demand for Synopsys' advanced design, verification, and simulation solutions…"
Discover why this Narrative puts Synopsys at 33% undervalued.
Before you lean too hard on any valuation output for Synopsys, it helps to know who is steering the ship, how their incentives are wired, and whether those rewards push in the same direction as shareholders. See who runs Synopsys and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com